Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Studies

SPECT Studies of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine: Comparison with PET, 124IMT and First Clinical Results

Karl-Josef Langen, Heinz H. Coenen, Norbert Roosen, Peer Kling, Otto Muzik, Hans Herzog, Torsten Kuwert, Gerhard Stöcklin and Ludwig E. Feinendegen
Journal of Nuclear Medicine March 1990, 31 (3) 281-286;
Karl-Josef Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heinz H. Coenen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Roosen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peer Kling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Muzik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Herzog
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torsten Kuwert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Stöcklin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludwig E. Feinendegen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 31, Issue 3
March 1, 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SPECT Studies of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine: Comparison with PET, 124IMT and First Clinical Results
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
SPECT Studies of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine: Comparison with PET, 124IMT and First Clinical Results
Karl-Josef Langen, Heinz H. Coenen, Norbert Roosen, Peer Kling, Otto Muzik, Hans Herzog, Torsten Kuwert, Gerhard Stöcklin, Ludwig E. Feinendegen
Journal of Nuclear Medicine Mar 1990, 31 (3) 281-286;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SPECT Studies of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine: Comparison with PET, 124IMT and First Clinical Results
Karl-Josef Langen, Heinz H. Coenen, Norbert Roosen, Peer Kling, Otto Muzik, Hans Herzog, Torsten Kuwert, Gerhard Stöcklin, Ludwig E. Feinendegen
Journal of Nuclear Medicine Mar 1990, 31 (3) 281-286;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study
  • Molecular Transport Mechanisms of Radiolabeled Amino Acids for PET and SPECT
  • PET and SPECT for Detection of Tumor Progression in Irradiated Low-Grade Astrocytoma: A Receiver-Operating-Characteristic Analysis
  • Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and 3-123I-Iodo-{alpha}-Methyl-L-Tyrosine SPECT in Brain Tumors
  • An Artificial Amino Acid, 4-Iodo-L-meta-Tyrosine: Biodistribution and Excretion via Kidney
  • Clinical Value of Iodine-123-Alpha-Methyl-L-Tyrosine Single-Photon Emission Tomography in the Differential Diagnosis of Recurrent Brain Tumor in Patients Pretreated for Glioma at Follow-Up
  • MR Imaging and Single-Photon Emission CT Findings after Gene Therapy for Human Glioblastoma
  • Correlation Between Postoperative 3-[123I]Iodo-L-{alpha}-Methyltyrosine Uptake and Survival in Patients with Gliomas
  • L-3-[123I]Iodo-{{alpha}}-Methyl-Tyrosine SPECT in Non-Small Cell Lung Cancer: Preliminary Observations
  • Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
  • Imaging of Soft-Tissue Tumors Using L-3-[Iodine-123]Iodo-{{alpha}}-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity
  • Google Scholar

More in this TOC Section

  • Evaluation of Therapy Response in Children with Untreated Malignant Lymphomas Using Technetium-99m-Sestamibi
  • Effect of Haloperidol Dose on Iodine-123-IBZM Brain SPECT Imaging in Schizophrenic Patients
  • Scintigraphy of Posterior Tibial Tendinitis
Show more Human Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire